The development could help scientists develop patient-specific treatments and one day offer a lab-grown lung transplant option.
Telemedicine significantly improved quality of life and inhaler technique in advanced COPD patients compared to traditional ...
RAHWAY, N.J.- Merck has completed its $10 billion buyout of the British biopharmaceutical company Verona. The deal was first ...
Samay founder and CEO Dr. Maria Artunduaga says things changed pretty quickly for her startup after winning the MedTech ...
Expedition Therapeutics Raises $165 Million in Oversubscribed Series A Financing to Advance Next-Generation DPP1 inhibitor ...
"These emissions drive global warming, exacerbating the very respiratory conditions inhalers are meant to relieve," ...
If you start to experience symptoms like chest pain, blue lips, or coughing up more than a teaspoon of blood, you should see ...
GlaxoSmithKline Plc said on Wednesday the U.S health regulator approved its lung disease drug Trelegy Ellipta for expanded use, making it the first inhaler delivering three drugs at once to be ...
GoodRx reports over 5.6 million Americans live in "pulmonology deserts," lacking accessible lung care, mostly in the central ...
Inhalers are the frontline treatment for asthma and COPD, but they come with a steep environmental cost, according to a new ...
The University of the Sunshine Coast has begun trialling a three in one inhaler to target better lung and heart health outcomes in chronic obstructive ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback